Dardenne M U, Koch H R, Klöckner H F
Klin Monbl Augenheilkd. 1985 Feb;186(2):87-92. doi: 10.1055/s-2008-1050881.
The present paper reports the first results with the Meditec OPL-3 neodymium:YAG laser (Rodenstock, Munich). The YAG laser is a pulsed laser, the biological effects of which are based on the formation of plasma at its focal point. Plasma formation induces a rapid explosion-like expansion of the tissue. This effect can be used to sever opaque structures of the refractive media of the eye, such as secondary cataracts, membranes or strands. The paper summarizes the results of the first 80 consecutive cases treated with the laser. The surgical procedure is described in detail. Visual acuity improved instantaneously in all cases in which no concomitant eye pathology (e.g., corneal or macular changes) existed. Complications consisted in the development of postoperative inflammatory reactions and increases in intraocular pressure, and responded well to corticosteroids and beta-blockers or Diamox. The development of the neodymium:YAG laser has considerably advanced our therapeutic possibilities.
本文报告了使用Meditec OPL - 3钕:钇铝石榴石激光（德国慕尼黑罗敦司得公司生产）取得的首批成果。钇铝石榴石激光是一种脉冲激光，其生物效应基于在焦点处形成等离子体。等离子体的形成会引发组织像爆炸一样快速膨胀。这种效应可用于切断眼屈光介质的不透明结构，如继发性白内障、膜或条索。本文总结了连续80例接受该激光治疗的首批病例的结果。详细描述了手术过程。在所有不存在伴随眼部病变（如角膜或黄斑改变）的病例中，视力立即得到改善。并发症包括术后炎症反应的发生和眼压升高，使用皮质类固醇、β受体阻滞剂或醋氮酰胺治疗效果良好。钕:钇铝石榴石激光的发展极大地拓展了我们的治疗可能性。
